---
title: 'Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic
  Review of Pipeline Developments'
date: '2024-05-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38710208/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240507180448&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Conventional antipsychotic drugs that attenuate dopaminergic
  neural transmission are ineffective in approximately one-third of patients with
  schizophrenia. This necessitates the development of non-dopaminergic ...'
disable_comments: true
---
INTRODUCTION: Conventional antipsychotic drugs that attenuate dopaminergic neural transmission are ineffective in approximately one-third of patients with schizophrenia. This necessitates the development of non-dopaminergic ...